IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study
Cheng, A. -L.1; Cornelio, G. H.2; Shen, L.3; Prince, T. J.4; Yang, T. -S.5; Chung, I. -J.6; Dai, G.7; Lin, J. -K.8; Sharma, A.9; Yeh, K. -H.1; Ma, B.10; Zaatar, A.11; Guan, Z.12; Masood, N.13; Srimuninnimit, V.14; Yau, T. Cheung15; Beier, F.16; Chatterjee, S.17; Lim, R. S. C.18
刊名ANNALS OF ONCOLOGY
2015-12-01
suppl.9页:45-46
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000367158700149
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/61743
Collection北京大学临床肿瘤学院
作者单位1.Taipei Vet Gen Hosp, Oncol, Taipei, Taiwan
2.All India Inst Med Sci, Oncol, New Delhi, India
3.Mt Miriam Hosp, Oncol, George Town, Malaysia
4.Aga Khan Univ Hosp, Oncol, Karachi, Pakistan
5.Mahidol Univ, Siriraj Hosp, Oncol, Bangkok 10700, Thailand
6.Merck KGaA, Global Biostat, Darmstadt, Germany
7.Merck Serono, Reg Med, Bombay, Maharashtra, India
8.Natl Univ Canc Inst, Oncol, Singapore, Singapore
9.San Juan de Dios Hosp, Oncol, Pasay City, Philippines
10.Queen Elizabeth Hosp, Oncol, Woodville, SA 5011, Australia
11.Chang Gung Mem Hosp Linkou, Oncol, Taoyuan, Taiwan
12.Natl Taiwan Univ Hosp, Oncol, Taipei, Taiwan
13.Peking Univ, Canc Hosp, Beijing Canc Hosp, Oncol, Beijing 100871, Peoples R China
14.Chonnam Natl Univ, Hwasun Hosp, Oncol, Hwasun Gun, South Korea
15.Gen Hosp Chinese Peoples Armed Police, Oncol, Beijing, Peoples R China
16.Chinese Univ Hong Kong, Prince Wales Hosp, Oncol, Hong Kong, Hong Kong, Peoples R China
17.Sun Yat Sen Univ, Oncol, Guangzhou 510275, Guangdong, Peoples R China
18.Univ Hong Kong, Queen Mary Hosp, Oncol, Hong Kong, Hong Kong, Peoples R China
Recommended Citation
GB/T 7714
Cheng, A. -L.,Cornelio, G. H.,Shen, L.,et al. Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study[J]. ANNALS OF ONCOLOGY,2015,suppl.9:45-46.
APA Cheng, A. -L..,Cornelio, G. H..,Shen, L..,Prince, T. J..,Yang, T. -S..,...&Lim, R. S. C..(2015).Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study.ANNALS OF ONCOLOGY,suppl.9,45-46.
MLA Cheng, A. -L.,et al."Association between early tumour shrinkage (ETS) and outcomes in RAS-wild type (WT) patients (pts) with metastatic colorectal cancer (mCRC) receiving first-line FOLFOX or FOLFIRI plus cetuximab every other week in the APEC study".ANNALS OF ONCOLOGY suppl.9(2015):45-46.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Cheng, A. -L.]'s Articles
[Cornelio, G. H.]'s Articles
[Shen, L.]'s Articles
百度学术
百度学术Similar articles in
[Cheng, A. -L.]'s Articles
[Cornelio, G. H.]'s Articles
[Shen, L.]'s Articles
必应学术
必应学术Similar articles in
[Cheng, A. -L.]'s Articles
[Cornelio, G. H.]'s Articles
[Shen, L.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.